Skip to content
Surf Wiki
Save to docs
general/brain-tumor

From Surf Wiki (app.surf) — the open knowledge base

Giant-cell glioblastoma

Tumor of the central nervous system


Summary

Tumor of the central nervous system

FieldValue
aboveGiant-cell glioblastoma
abovestylebackground:lightgrey;
image[[File:AFIP-00405562-GiantCellGlioblastoma-Gross.jpg200px]]
captionSome glioblastomas, such as this giant-cell variant, are discrete firm masses which clinically and radiographically simulate metastatic carcinoma
headerstylebackground:lightgrey;
header1WHO Classification
label2Standard name
data2Giant-cell glioblastoma
label3Structure
data3*Neuroepithelial tumors*
└►Astrocytic tumors
└►Glioblastoma
└►Giant-cell glioblastoma
header4ICD-O Code & WHO Grade
label5ICD-O Code
data59441/3
label6WHO Grade
data6IV
header7Synonyms & Acronyms
label8Synonyms
data8Monstrocellular sarcoma
header9Epidemiology
label10Incidence
data100.15/100,000/y
new cases/population/year
label11Age peak
data1142
label12M/F ratio
data121.6
header13Prognosis
label14Mean overall survival
data1412 months
belowstylebackground:lightgrey;
belowMedicine WikiProject/Neurology task force

└►Astrocytic tumors └►Glioblastoma └►Giant-cell glioblastoma new cases/population/year

The giant-cell glioblastoma is a histological variant of glioblastoma, presenting a prevalence of bizarre, multinucleated (more than 20 nuclei) giant (up to 400 μm diameter) cells.

It occasionally shows an abundant stromal reticulin network and presents a high frequency of TP53 gene mutations.

Symptoms and signs are similar to those of the ordinary glioblastoma. Methodology of diagnosis and treatment are the same.

Prognosis is similar to the ordinary glioblastoma, which is approximately 12 months, although some authors refer to cases with a slightly better outcome.

Historical annotation

The giant-cell glioblastoma was originally termed monstrocellular sarcoma, because of its stromal reticulin network, but the astrocytic nature of the tumor was firmly established through the consistent GFAP expression analysis.

Epidemiology

Incidence

The giant-cell glioblastoma is a rare neoplasia: its incidence is less than 1% of all brain tumors. It represents up to 5% of glioblastomas.

Age and sex distribution

The mean age at clinical presentation is 42. The age distribution includes children and has a wider range than other diffuse astrocytomas (diffuse WHO grade II astrocytoma, anaplastic astrocytoma, ordinary glioblastoma).

The giant-cell glioblastoma affects males more frequently (the M/F ratio is 1.6).

Prognosis

Most patients with giant-cell glioblastoma have unfavourable prognosis, but some authors report clinical results slightly better than the ordinary glioblastoma, in all probability because this variant seems less infiltrative, due to the nature of giant cells of this type.

References

References

  1. (September 2010). ["Pathology and Genetics of Tumours of the Nervous System"](https://archive.org/details/pathologygenetic0000unse }}{{Page needed). IARC.
  2. Macchi G.. (September 2010). "Malattie del sistema nervoso". PICCIN Editore.
  3. (September 2010). "Cancer Management: A Multidisciplinary Approach".
  4. Zulch KJ. (September 2010). "Histological Typing of Tumours of the Central Nervous System". World Health Organization.
  5. Zulch KJ. (September 2010). "Brain Tumors: Their Biology and Pathology". Springer Verlag.
  6. (March 1979). "GFA and S 100 protein levels as an index for malignancy in human gliomas and neurinomas". Journal of the National Cancer Institute.
  7. (September 2010). "Histological Typing of Tumours of the Central Nervous System". Springer Verlag.
  8. (September 2010). "Pathology of Tumors of the Nervous System". Edward Arnold.
  9. (1989). "Malignant monstrocellular brain tumours. A study of 42 surgically treated cases". Acta Neurochirurgica.
  10. (September 1997). "Molecular genetic analysis of giant-cell glioblastomas". The American Journal of Pathology.
  11. (November 1997). "p53 mutations versus EGF receptor expression in giant-cell glioblastomas". Journal of Neuropathology and Experimental Neurology.
  12. (April 1996). "A clinico-immunohistochemical study of giant cell glioblastoma". Nōshuyō Byōri.
  13. (February 1989). "Giant-celled glioblastoma of brain. A clinico-pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure)". Cancer.
  14. (August 2004). "The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme". Journal of Neurosurgery.
  15. (January 1967). "Glial origin of monstrocellular tumor. Case report of prolonged survival". Journal of Neurosurgery.
  16. (September 1980). "Histologic factors of prognostic significance in the glioblastoma multiforme". Cancer.
  17. (June 1998). "Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period". Child's Nervous System.
Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about Giant-cell glioblastoma — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report